- Location
- Montréal, Canada
Nestlé Health Science Licenses Rights to Novel Ulcerative Colitis Therapy (LT-02,phosphatidylcholine)
Pretty interesting results show improuvement of UC with a special formula of delayed soy lechitin versus placebo, from Lipid Therapeutics, Germany:
''First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses''
article: http://www.nature.com/ajg/journal/v109/n7/full/ajg2014104a.html
Furthermore, Nestlé Health Science would commercialize the product:
https://www.nestlehealthscience.com...es-rights-to-novel-ulcerative-colitis-therapy
Anyone aware of more details, availability or has tested this product?
I have just contacted Nestlé to inquire furthermore, waiting for reply...
I would really like to try it asap!!!
Pretty interesting results show improuvement of UC with a special formula of delayed soy lechitin versus placebo, from Lipid Therapeutics, Germany:
''First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses''
article: http://www.nature.com/ajg/journal/v109/n7/full/ajg2014104a.html
Furthermore, Nestlé Health Science would commercialize the product:
https://www.nestlehealthscience.com...es-rights-to-novel-ulcerative-colitis-therapy
Anyone aware of more details, availability or has tested this product?
I have just contacted Nestlé to inquire furthermore, waiting for reply...
I would really like to try it asap!!!